Top Markets
#1 OriginTrail OriginTrail +30.06%
#2 Pons Pons +14.37%
#3 MarsCoin MarsCoin +11.97%
#4 Tutorial Tutorial +11.76%
#5 Waves Waves +10.06%
#6 Siren Siren +8.59%
#7 Synapse Synapse +8.08%
#8 Cortex Cortex +7.78%
#9 TROLL TROLL +6.22%
#10 Concordium Concordium +6.10%
Coin of the day
OriginTrail OriginTrail
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
Chunghwa Chemical Synthesis & Biotech Co., Ltd. Chunghwa Chemical Synthesis & Biotech Co., Ltd.

Chunghwa Chemical Synthesis & Biotech Co., Ltd.

1762
Classifica tra le azioni #22434
Based in New Taipei City, Taiwan, Chunghwa Chemical Synthesis & Biotech Co.,... Based in New Taipei City, Taiwan, Chunghwa Chemical Synthesis & Biotech Co., Ltd., established in 1964 and previously known as China Chemical Synthesis Industry Co., Ltd., specializes in the development, production, and distribution of active pharmaceutical ingredients (APIs). The company's market reach includes Taiwan and the United States. Their API portfolio encompasses products designed for immunosuppression, oncology, and cardiovascular conditions, in addition to various peptide compounds. Moreover, they manufacture a wide array of bulk pharmaceutical substances for numerous therapeutic applications, including anti-anxiety agents, antidiabetics, laxatives, antifungals, antihistamines, antiseptics, antiulcerants, cardiovascular medications, skeletal muscle relaxants, hypolipidemics, antineoplastics, antihyperlipidemics, and immunosuppressants. Complementing its product offerings, Chunghwa Chemical Synthesis & Biotech delivers bespoke research and development as well as contract manufacturing services to both emerging drug developers and established generic pharmaceutical firms.
Prezzo delle azioni
$1.15
Ultima sincronizzazione: 2026-08-21
Capitalizzazione di mercato
$88.79M
Variazione (1 giorno)
2.54%
Variazione (1 anno)
27.30%
Paese
TW
Scambia Chunghwa Chemical Synthesis & Biotech Co., Ltd. (1762)

Categoria

Healthcare
Utile per Chunghwa Chemical Synthesis & Biotech Co., Ltd. (1762)
Utile nel 2026 TTM: 0
Secondo gli ultimi rapporti finanziari di Chunghwa Chemical Synthesis & Biotech Co., Ltd., gli utili attuali della società sono 0. Nel 2026, la società ha registrato un utile di 0, uguale a agli utili del 2026, che erano di 0. Gli utili mostrati in questa pagina sono quelli prima degli interessi e delle imposte, ovvero EBIT.
Storico degli utili di Chunghwa Chemical Synthesis & Biotech Co., Ltd. dal 2026 al 2026
Utile alla fine di ogni anno
Anno Utile Cambia
Non abbastanza dati per le date fornite.
Utile per aziende simili o concorrenti
Azienda Utile Differenza negli utili Il paese
Royalty Pharma plc Royalty Pharma plc
Royalty Pharma plc
RPRX.US
$1.35B -
US
Swedish Orphan Biovitrum AB Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB
SOBI.ST
- -
SE
Ipsen S.A. Ipsen S.A.
Ipsen S.A.
IPN.PA
- -
FR
Corcept Therapeutics Incorporated Corcept Therapeutics Incorporated
Corcept Therapeutics Incorporated
CORT.US
$26.37M -
US
Recordati Industria Chimica e Farmaceutica S.p.A. Recordati Industria Chimica e Farmaceutica S.p.A.
Recordati Industria Chimica e Farmaceutica S.p.A.
REC.MI
- -
IT